Stage IIIB Colorectal Cancer AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14917 | Ceralasertib | 1 | Recruiting | 1 |
| DB08937 | TAS-102 | 1 | Recruiting | 1 |
| DB11760 | Talazoparib | 1 | Recruiting | 1 |
| DB04485 | Thymidine | 1 | Recruiting | 1 |
| DB09343 | Tipiracil | 1 | Recruiting | 1 |
| DB14962 | Trastuzumab deruxtecan | 1 | Recruiting | 1 |
| DB00432 | Trifluridine | 1 | Recruiting | 1 |
| DB12001 | Abemaciclib | 1 / 2 | Active Not Recruiting | 1 |
| DB00002 | Cetuximab | 1 / 2 | Active Not Recruiting | 1 |
| DB00002 | Cetuximab | 1 / 2 | Recruiting | 1 |
| DB11718 | Encorafenib | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB11105 | Benzalkonium | 2 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
| DB00002 | Cetuximab | 2 | Active Not Recruiting | 1 |
| DB14825 | Danvatirsen | 2 | Active Not Recruiting | 1 |
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
| DB00762 | Irinotecan | 2 | Active Not Recruiting | 2 |
| DB08890 | Linaclotide | 2 | Active Not Recruiting | 1 |
| DB01269 | Panitumumab | 2 | Active Not Recruiting | 2 |
| DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |
| DB15102 | Pemigatinib | 2 | Active Not Recruiting | 1 |
| DB08896 | Regorafenib | 2 | Active Not Recruiting | 3 |
| DB16425 | Rintatolimod | 2 | Withdrawn | 1 |
| DB08937 | TAS-102 | 2 | Active Not Recruiting | 3 |
| DB04485 | Thymidine | 2 | Active Not Recruiting | 1 |
| DB09343 | Tipiracil | 2 | Active Not Recruiting | 3 |
| DB00432 | Trifluridine | 2 | Active Not Recruiting | 3 |
| DB00135 | Tyrosine | 2 | Active Not Recruiting | 1 |